CEL-SCI Past Earnings Performance

Past criteria checks 0/6

CEL-SCI's earnings have been declining at an average annual rate of -2.2%, while the Biotechs industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 72.6% per year.

Key information

-2.2%

Earnings growth rate

6.1%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate-72.6%
Return on equity-343.5%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CEL-SCI makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:LSRM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-2990
31 Mar 240-3090
31 Dec 230-3190
30 Sep 230-3290
30 Jun 230-3490
31 Mar 230-3590
31 Dec 220-37100
30 Sep 220-38110
30 Jun 220-37110
31 Mar 220-36120
31 Dec 210-37130
30 Sep 210-37130
30 Jun 210-34130
31 Mar 210-35130
31 Dec 201-33120
30 Sep 201-30120
30 Jun 201-30110
31 Mar 201-32100
31 Dec 190-2990
30 Sep 190-2280
30 Jun 191-3260
31 Mar 191-2660
31 Dec 181-2450
30 Sep 180-3260
30 Jun 180-2270
31 Mar 180-2070
31 Dec 170-2470
30 Sep 170-1460
30 Jun 170-1080
31 Mar 170-1080
31 Dec 160-1070
30 Sep 160-1280
30 Jun 160-2070
31 Mar 160-2180
31 Dec 151-25100
30 Sep 151-35140
30 Jun 151-32150
31 Mar 150-30150
31 Dec 140-31140
30 Sep 140-28110
30 Jun 140-2380
31 Mar 140-257-5
31 Dec 130-1270

Quality Earnings: LSRM is currently unprofitable.

Growing Profit Margin: LSRM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LSRM is unprofitable, and losses have increased over the past 5 years at a rate of 2.2% per year.

Accelerating Growth: Unable to compare LSRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LSRM is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-13.8%).


Return on Equity

High ROE: LSRM has a negative Return on Equity (-343.45%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies